$4.63
-0.14-3.04%
마지막 업데이트: Aug 20, 10:21 AM
Benzinga
Benzinga
Benzinga
목요일, 8월 20
Galmed Pharmaceuticals Ltd
GLMDNASDAQ
PRO
주식 분할: Galmed Pharmaceuticals Ltd는 최근 분할했습니다.
Wednesday, August 19, 2026 비율로
1:8
Galmed Pharmaceuticals Earnings & Forecasts
Galmed Pharmaceuticals (GLMD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Galmed Pharmaceuticals Guidance
Recent Earnings Results
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.38 | $-0.51 | $-0.54 | $-0.79 |
| Actual | $-0.29 | $-0.92 | $-0.33 | $-0.63 |
| Surprise | +23.7% | -80.4% | +38.9% | +24.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '26E | Q3 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-3.12 | $-3.12 |
| Revenue | ||
| Consensus | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved